Publication

Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib

Chat with Graph Search

Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor–Positive Early Breast Cancer: A Nationwide Cohort Study

HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine

Development of cysteine cathepsin inhibitors combined with cell type-specific delivery for the treatment of B-cell lymphoma and solid tumors

Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening

Metabolic dependencies of metastasis-initiating cells in female breast cancer

Intraductal xenografts model estrogen receptor-positive (ER+) breast cancer dormancy and reveal a critical role for epithelial-mesenchymal transition (EMT) in its establishment

Multifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine

A novel culture method that sustains ER alpha signaling in human breast cancer tissue microstructures

Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis

Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions

Antiproliferative activity of ruthenium and osmium clusters with phosphine ligands

Development of mass spectrometric methods to understand the mechanism of action of transition metal-based anticancer compounds

Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation

Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit

Mechanisms underlying cell-fate determination in the mammary gland development

In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)-Cl-2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas

Identification and Preclinical Validation of Novel Inhibitors of the Notch Pathway

X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins